|
Kaiser Permanente Northern California |
Cynthia I. Campbell, PhD, MPH (Contact Principal Investigator)
Opioids, cannabis, pain, treatment, youth, primary care, patient-engagement, electronic health record, comorbidities, delivery science, mental health |
 |
|---|
|
Constance Weisner, DrPH, MSW (Other Significant Contributor) Alcohol, opioids, mental health, chronic pain, HIV, youth, primary care, patient-centered outcomes research (PCOR), longitudinal observational studies, comorbidities, implementation research, economics, genomics
|
 |
|---|
|
Kaiser Permanente Washington's Health Research Institute |
Katharine Bradley, MD, MPH (Principal Investigator)
Alcohol, opioids, mental health, primary care, prevention, youth, PCOR, implementation research, quality measurement, NLP, user-centered design; eHealth, genomics
|
 |
|---|
Baylor, Scott & White Health
|
Katherine Sanchez (Site PI) Integrated health care and the provision of socio-culturally, linguistically adapted models for the treatment of co-morbid mental and physical illness. system level interventions and research opportunities to understand the social determinants of health and result in high impact, innovative strategies to address mental health disparities |
|
|---|
|
Essentia Health |
Irina V. Haller, PhD, MS (Site PI) Rural and minority health with emphasis on assessment of vitamin D status and its relation to chronic diseases; and health issues in older adults |
 |
|---|
|
Fallon Health |
Susan Andrade, ScD (Site-PI) Pharmacoepidemiology and medication safety, epidemiology of chronic diseases |
 |
|---|
|
Geisinger Health System |
Melissa Poulsen, PhD, MPH (Site PI) Community and environmental determinants of health, childhood obesity, type 2 diabetes, and opioid use disorder |
 |
|---|
|
Harvard Pilgrim Health Care |
Christine Lu MSc, PhD (Site PI) Evaluations of health policies in developing and developed countries using large, longitudinal administrative healthcare data and rigorous quasi-experimental research methods; policy, legal, ethical, economic and societal issues of precision medicine |
 |
|---|
|
Henry Ford Health System |
Brian Ahmedani, PhD (Site PI) Alcohol, mental health, suicide, prescription opioids, hospital readmissions, genomics, youth, eHealth, clinician attitudes on SUD & mental health care, chronic disease, economics of mental health care |
 |
|---|
|
Kaiser Permanente Colorado |
Ingrid Binswanger, MD, MPH (Site PI) Alcohol, opioids, mental health, PC, implementation research, quality management, opioids, suicide, prisoners, youth, other prescription drug abuse, medication safety, SU-related infections, worker productivity, economics |
 |
|---|
|
Kaiser Permanente Georgia | Drew Bradlyn, PhD (Site PI) Youth, mental health, clinical trials, prescription drug abuse, policy |
|
|---|
|
Kaiser Permanente Hawaii |
Kristina Phillips, PhD (Site PI)
High-risk substance use practices that contribute to negative health outcomes, brief interventions, treatment outcome, and ecological momentary assessment, and social determinants of health |
|
|---|
Kaiser Permanente Mid-Atlantic
|
Douglas W. Roblin, PhD (Site PI) Health service outcomes for HIV-infected patients, including determinants of optimized multidisciplinary care for maximized HIV outcomes, medication adherence issues in these patients, and epidemiology of the disease, other sexually transmitted diseases and hepatitis |
 |
|---|
|
Kaiser Permanente Northwest |
Bobbi Jo Yarborough, PsyD (Site PI) Prescribed and illicit opioid use, depression, eating disorders, obesity, cognitive behavioral therapy, qualitative methods |
 |
|---|
|
Kaiser Permanente Southern California |
Rulin Hechter, MD, PhD (Site PI) Mental health, behavioral health integration, HCV, HIV, youth, medication safety
|
 |
|---|
|
Palo Alto Medical Foundation |
Dominick L. Frosch PhD (Site PI) Intervention development, randomized efficacy and effectiveness trials, implementation science, measurement and qualitative methods
|
 |
|---|
Veterans Affairs Puget Sound (VA)
|
Emily Williams, PhD MPH (Site PI) Increasing access to evidence-based treatments for unhealthy alcohol and other substance use in diverse medical settings, including understanding and promoting equity in this care for vulnerable patient subpopulations
|
 |
|---|
